[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 100658
1. Sabanathan S, Oomeer S, Jenkinson LR: Cholecystectomy or Cholelithiasis - a Missed Marker for Hyperlipidaemia? A Combined Retrospective and Prospective Study. Gastroenterology Res; 2008 Dec;1(1):29-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Multiple studies have shown an association between gallstones and abnormal lipids and the latter increases the risk of coronary artery disease and stroke.
  • Only 36.2% of women and 36.9% of men who had a cholecystectomy had a full lipid profile including high density lipoproteins (HDL) and low density lipoproteins (LDL).
  • Of these, 76.4% of women and 70.7% of men had an abnormal lipid profile.
  • In the prospective group, 91.1 % of women and 96.3 % of men had a full lipid profile.
  • These were abnormal in 81.4% of women and 70.4 % of men.
  • Current guidelines suggest they are at an increased risk of cardiovascular disease and should be treated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27994703.001).
  • [ISSN] 1918-2805
  • [Journal-full-title] Gastroenterology research
  • [ISO-abbreviation] Gastroenterology Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; cholecystectomy / gallstones hypercholesterolaemia / hyperlipidaemia / hypertri-glyceridaemia
  •  go-up   go-down


2. Williams DA: Of Mouse Models and Men. Mol Ther; 2007 Apr;15(4):643

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Of Mouse Models and Men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28192701.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Editorial
  • [Publication-country] United States
  •  go-up   go-down


3. Aaltonen M, Forma L, Rissanen P, Raitanen J, Jylhä M: Transitions in health and social service system at the end of life. Eur J Ageing; 2010 Jun;7(2):91-100

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transitions in health and social service system at the end of life.
  • The data set, derived from multiple national registers, consists of 75,578 people who died between 1998 and 2001.
  • The place of death varied by age and gender: men and people in younger age groups died more often in general or in university hospital or at home, while dying in health centres or in residential care homes was more common among women or the very old.
  • Men and younger age groups had more transitions than women and older age groups.
  • Among men and younger age groups transitions between home and general or university hospital were common while transitions between home and health centre or residential care were more common to women and older people.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Z Gerontol Geriatr. 2004 Dec;37(6):467-74 [15614599.001]
  • [Cites] Am J Geriatr Psychiatry. 1999 Spring;7(2):139-46 [10322241.001]
  • [Cites] Gerontologist. 2009 Feb;49(1):34-45 [19363002.001]
  • [Cites] Int J Nurs Pract. 2008 Aug;14(4):308-14 [18715393.001]
  • [Cites] J Epidemiol Community Health. 2006 May;60(5):412-6 [16614331.001]
  • [Cites] J Adv Nurs. 1997 Sep;26(3):602-7 [9378883.001]
  • [Cites] Eval Health Prof. 2001 Dec;24(4):385-403 [11817198.001]
  • [Cites] Am J Public Health. 1991 Apr;81(4):443-7 [2003621.001]
  • [Cites] Gerontologist. 2002 Oct;42 Spec No 3:54-67 [12415134.001]
  • [Cites] JAMA. 1999 Feb 17;281(7):613-20 [10029122.001]
  • [Cites] QJM. 2005 Dec;98(12):865-70 [16299059.001]
  • [Cites] J Aging Health. 1996 Aug;8(3):307-19 [10165977.001]
  • [Cites] BMC Health Serv Res. 2006 Sep 04;6:110 [16952306.001]
  • [Cites] Gerontologist. 2002 Jun;42(3):304-14 [12040132.001]
  • [Cites] Soc Sci Med. 2006 Nov;63(9):2367-80 [16884840.001]
  • [Cites] Scand J Caring Sci. 2006 Mar;20(1):10-7 [16489955.001]
  • [Cites] Cancer Nurs. 2003 Jun;26(3):245-51 [12832958.001]
  • [Cites] J Pain Symptom Manage. 2009 May;37(5):930-3 [19414098.001]
  • [Cites] Am J Nurs. 2008 Sep;108(9 Suppl):58-63; quiz 63 [18797231.001]
  • [Cites] J Nurs Manag. 2004 Sep;12(5):309-16 [15315486.001]
  • [Cites] BMC Palliat Care. 2005 Feb 22;4(1):3 [15725350.001]
  • [Cites] J Adv Nurs. 1997 Jun;25(6):1233-40 [9181422.001]
  • [Cites] J Palliat Med. 2008 Apr;11(3):416-21 [18363481.001]
  • [Cites] Am J Nurs. 2005 Feb;105(2):52-61; quiz 61-2 [15674058.001]
  • [Cites] Duodecim. 1990;106(21):1443-50 [1364673.001]
  • [Cites] Arch Intern Med. 2000 Mar 27;160(6):743-7 [10737273.001]
  • [Cites] PLoS Med. 2006 Oct;3(10 ):e397 [17076551.001]
  • [Cites] Am J Nurs. 2003 Jul;103(7):42-52; quiz 53 [12865640.001]
  • [Cites] Eur J Public Health. 2009 Jun;19(3):313-8 [19286838.001]
  • [Cites] JAMA. 2007 Oct 10;298(14):1638-9 [17925515.001]
  • [Cites] J Adv Nurs. 2005 Oct;52(1):14-21 [16149976.001]
  • [Cites] Scand J Caring Sci. 2002 Dec;16(4):360-7 [12445105.001]
  • [Cites] Disabil Rehabil. 2005 Sep 30-Oct 15;27(18-19):1053-60 [16278174.001]
  • [Cites] Scand J Public Health. 2008 Jan;36(1):35-43 [18426783.001]
  • [Cites] BMC Health Serv Res. 2009 Aug 05;9:139 [19656358.001]
  • [Cites] Am J Public Health. 1992 Aug;82(8):1093-8 [1386195.001]
  • [Cites] Health Soc Care Community. 2005 Sep;13(5):420-30 [16048530.001]
  • (PMID = 28798621.001).
  • [ISSN] 1613-9372
  • [Journal-full-title] European journal of ageing
  • [ISO-abbreviation] Eur J Ageing
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Ageing / Last years of life / Place of death / Register study / Transitions in health and social service system
  •  go-up   go-down


Advertisement
4. Parker MG, Schön P, Lagergren M, Thorslund M: Functional ability in the elderly Swedish population from 1980 to 2005. Eur J Ageing; 2008 Dec;5(4):299-309

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study looks at ages 65-84 (<i>n</i> ≈ 3,000 per year) and presents prevalence rates for functional ability (walking and running ability, vision and hearing, and disability) for different age groups and for men and women.
  • Prevalence rates of functional problems increase with age, for all indicators and for men and women.
  • With the exception of hearing, women have poorer function than men.
  • Results emphasize the necessity to follow population trends over long periods of time with multiple waves and multiple indicators.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Aging Soc Policy. 2000;12(1):73-90 [11284197.001]
  • [Cites] Gerontologist. 2007 Apr;47(2):150-8 [17440120.001]
  • [Cites] Soc Sci Med. 2003 Dec;57(12):2411-22 [14572847.001]
  • [Cites] Scand J Public Health Suppl. 2001;58:117-31 [11708622.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1351-5 [16282573.001]
  • [Cites] J Epidemiol Community Health. 2003 Oct;57(10):778-83 [14573579.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2004 Jun;59(6):M590-7 [15215269.001]
  • [Cites] J Gerontol B Psychol Sci Soc Sci. 2007 Jan;62(1):S3-S10 [17284564.001]
  • [Cites] Scand J Public Health. 2005;33(2):151-5 [15823977.001]
  • [Cites] Scand J Public Health Suppl. 2006 Jun;67:185-98 [16762910.001]
  • (PMID = 28798582.001).
  • [ISSN] 1613-9372
  • [Journal-full-title] European journal of ageing
  • [ISO-abbreviation] Eur J Ageing
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Functioning / Health trends / Mobility
  •  go-up   go-down


5. Gaymu J, Ekamper P, Beets G: Future trends in health and marital status: effects on the structure of living arrangements of older Europeans in 2030. Eur J Ageing; 2008 Mar;5(1):5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Future changes in the marital status of the older people will result in a higher proportion living in their own homes: women in each age group will more often grow old living with their partner, and this will also apply, to a lesser extent, to men aged 85 and over.
  • Both men and women will be less likely to live alone, with people other than a partner, or in institutions.
  • But for men aged 74-84 the likelihood of choosing one or another type of living arrangement will remain remarkably stable in the future.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gerontol B Psychol Sci Soc Sci. 1995 May;50(3):S164-72 [7767700.001]
  • [Cites] Popul Trends. 2004 Spring;(115):24-34 [15192891.001]
  • [Cites] J Gerontol. 1991 Jan;46(1):S1-8 [1986045.001]
  • [Cites] Res Aging. 1988 Jun;10(2):235-57 [3175324.001]
  • [Cites] J Gerontol. 1990 Nov;45(6):S238-49 [2229950.001]
  • [Cites] Demography. 2000 May;37(2):221-36 [10836180.001]
  • [Cites] Gerontologist. 1995 Dec;35(6):724-31 [8557200.001]
  • [Cites] Res Aging. 1990 Sep;12(3):339-63 [2146734.001]
  • [Cites] Math Popul Stud. 1999;7(3):239-78, 308 [12295226.001]
  • [Cites] Demography. 1980 Feb;17(1):39-56 [7353707.001]
  • [Cites] J Gerontol B Psychol Sci Soc Sci. 1996 Mar;51(2):S61-9 [8785694.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1351-5 [16282573.001]
  • [Cites] Gerontologist. 1995 Dec;35(6):771-91 [8557205.001]
  • [Cites] J Aging Health. 1997 Feb;9(1):126-43 [10182414.001]
  • (PMID = 28798558.001).
  • [ISSN] 1613-9372
  • [Journal-full-title] European journal of ageing
  • [ISO-abbreviation] Eur J Ageing
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Ageing / Europe / Living arrangements / Projections
  •  go-up   go-down


6. Mason PK, Moorman L, Lake DE, Mangrum JM, DiMarco JP, Ferguson JD, Mahapatra S, Bilchick KC, Wiggins D, Mounsey JP, Moorman JR: Gender and Racial Characteristics of Patients Referred to a Tertiary Atrial Fibrillation Center. J Atr Fibrillation; 2010 Dec;3(4):301
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twice as many men were referred as women (570 vs. 1094; P<0.0001).
  • Women were older (68.0±11.9 vs. 62.4±13.0 years; P<0.0001) and more symptomatic with palpitations (80% vs. 73%; P=0.008), but otherwise were not substantially different from men.
  • Our referring physicians treated the majority of both men and women with anticoagulant and rate-controlling medications.
  • In contrast, they accounted for 7.4% of patients seen for a primary diagnosis of AF at all other UVA outpatient clinics (P<0.0001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Value Health. 2006 Sep-Oct;9(5):348-56 [16961553.001]
  • [Cites] Curr Opin Cardiol. 2010 Jan;25(1):8-15 [19940767.001]
  • [Cites] Heart Rhythm. 2007 Mar;4(3 Suppl):S1-6 [17336876.001]
  • [Cites] N Engl J Med. 1999 Feb 25;340(8):618-26 [10029647.001]
  • [Cites] J Med Ethics. 2006 Aug;32(8):435-8 [16877620.001]
  • [Cites] Am J Cardiol. 1990 May 1;65(16):1112-6 [2330896.001]
  • [Cites] N Engl J Med. 2002 Dec 5;347(23):1834-40 [12466507.001]
  • [Cites] Am Heart J. 2009 Jul;158(1):111-7 [19540400.001]
  • [Cites] J Am Coll Cardiol. 2007 Feb 6;49(5):572-7 [17276181.001]
  • [Cites] J Am Coll Cardiol. 2005 Oct 4;46(7):1307-8 [16198848.001]
  • [Cites] Circulation. 2004 Jun 29;109(25):3223-43 [15226233.001]
  • [Cites] Pacing Clin Electrophysiol. 2009 May;32(5):622-6 [19422583.001]
  • [Cites] J Natl Med Assoc. 2008 Feb;100(2):237-45 [18300541.001]
  • [Cites] Europace. 2007 Aug;9(8):613-20 [17636302.001]
  • [Cites] Int J Gynaecol Obstet. 2007 Jul;98(1):75-9 [17459386.001]
  • [Cites] Circulation. 1998 Sep 8;98(10):946-52 [9737513.001]
  • [Cites] JAMA. 1994 Mar 16;271(11):840-4 [8114238.001]
  • [Cites] Cardiol Clin. 2009 Feb;27(1):13-24, vii [19111760.001]
  • [Cites] J Cardiovasc Electrophysiol. 2007 Jan;18(1):23-8 [17081205.001]
  • [Cites] Am J Cardiol. 2009 Dec 1;104(11):1534-9 [19932788.001]
  • [Cites] Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2455-8 [9825366.001]
  • [Cites] Gend Med. 2009 Sep;6(3):419-32 [19850238.001]
  • [Cites] Am J Cardiol. 2007 Sep 15;100(6):924-9 [17826371.001]
  • [Cites] Heart Rhythm. 2010;7(2):167-72 [20022814.001]
  • [Cites] JAMA. 2001 May 9;285(18):2370-5 [11343485.001]
  • (PMID = 28496679.001).
  • [Journal-full-title] Journal of atrial fibrillation
  • [ISO-abbreviation] J Atr Fibrillation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Khaykin Y, Skanes A, Wulffhart ZA, Gula L, Whaley B, Oosthuizen R, Seabrook C, Beardsall M, Verma A: Intracardiac ECHO Integration with Three Dimensional Mapping: Role in AF Ablation. J Atr Fibrillation; 2008 Jul-Aug;1(2):32
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • <b>Methods:</b> Between February and May 2007, 15 patients (100% men, 10 with paroxysmal AF) presenting for AF ablation were offered mapping using a novel system integrating 3D mapping and ICE.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cardiovasc Electrophysiol. 2007 Mar;18(3):276-82 [17284265.001]
  • [Cites] Circulation. 1999 Sep 14;100(11):1203-8 [10484541.001]
  • [Cites] J Cardiovasc Electrophysiol. 2004 Nov;15(11):1335-40 [15574190.001]
  • [Cites] Circ Arrhythm Electrophysiol. 2008 Jun 1;1(2):110-9 [19808401.001]
  • [Cites] J Am Coll Cardiol. 2002 Aug 7;40(3):464-74 [12142112.001]
  • [Cites] Heart Rhythm. 2007 May;4(5):595-602 [17467627.001]
  • [Cites] Circulation. 2000 Nov 21;102(21):2619-28 [11085966.001]
  • (PMID = 28496579.001).
  • [Journal-full-title] Journal of atrial fibrillation
  • [ISO-abbreviation] J Atr Fibrillation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Harrison M: Fifty per cent of society is still undervalued in nursing. Nurs Stand; 2009 Nov 11;24(10):33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Other men often say they think I am too assertive to be a nurse.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28061101.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. 'Despicable' attack on district nurse adds to fear of violence. Nurs Stand; 2007 Aug 01;21(47):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Police are hunting a gang of four men who robbed and terrorised a district nurse as she visited a patient at home in the afternoon.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001601.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


10. Bartlett A: Breast cancer. Nurs Stand; 2009 Jul 29;23(47):59-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although the cancer is more prevalent among women, it is estimated that more than 300 men are also diagnosed with breast cancer annually ( Cancer Research UK 2008 ).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28041051.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


11. Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men John A Rich Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men Johns Hopkins University Press 212pp $24.95 /£13 978 0 8018 9363 6 0801893631 [Formula: see text]. Nurs Stand; 2010 Mar 31;24(30):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men John A Rich Wrong Place, Wrong Time - Trauma and Violence in the Lives of Young Black Men Johns Hopkins University Press 212pp $24.95 /£13 978 0 8018 9363 6 0801893631 [Formula: see text].
  • He dissects with powerful reality the sad, destructive and mindless cycle of violence among young black men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029869.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


12. More young women killed in alcohol-related car accidents. Nurs Stand; 2010 Mar 31;24(30):16

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Young men have greater representation in fatal alcohol-related accidents.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029892.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


13. 'She was a tall, dark heart specialist...'. Nurs Stand; 2005 Jan 19;19(19):7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Romantic novel publishers Mills & Boon are appealing for nurses to become authors for its medical romance series of 'exciting, sensual love stories featuring confident, sensitive men and dedicated caring women'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28006489.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


14. McCreaddie M: Little Britain makes our world a better place. Nurs Stand; 2005 Dec 07;20(13):39

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He finds the TV series 'offensive' in its use of humour involving 'people in wheelchairs, working-class women and gay men'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001808.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


15. Osteoporitic fractures increase mortality risk for five to ten years. Nurs Stand; 2009 Jun 03;23(39):16-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Low trauma fractures in older men and women are associated with increased mortality risk for five to ten years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996856.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


16. Students campaign against bar on bisexual and gay blood donors. Nurs Stand; 2006 Feb 22;20(24):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The National Union of Students (NUS) is urging its members to become blood donors to counteract the numbers lost because gay and bisexual men are not allowed to donate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27977969.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. King MT, Viney R, Hossain I, Smith D, Savage E, Stockler MR, Armstrong B: Survival gains needed to justify the side effects of treatment for localized prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):5119

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 5119 Background: Men diagnosed with localized prostate cancer face difficult treatment decisions.
  • METHODS: QOL data were collected prospectively 3 years post-diagnosis in a population-based cohort of men treated for localized prostate cancer (n=1642); these data were used to identify common side-effect profiles.
  • RESULTS: The table shows the survival gains needed for a range of common treatment profiles, relative to the base case of active surveillance (in which men typically experienced mild loss of libido and mild fatigue).
  • For example, radical prostatectomy often resulted in severe impotence and mild urinary leakage; men required an extra 8.0 months (95% CI 7.4-8.7) of life to make this worthwhile.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964386.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Lin D, Smith MR, Morton RA, Steiner MS: Use of age and BMD to predict fracture risk in men on androgen deprivation therapy. J Clin Oncol; 2009 May 20;27(15_suppl):9517

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of age and BMD to predict fracture risk in men on androgen deprivation therapy.
  • We recently completed a two-year trial in 1382 men in which we examined the ability of toremifene to reduce fracture risk in men on ADT.
  • METHODS: We conducted a randomized double blind placebo controlled trial in 1382 men with histologically confirmed prostate cancer on ADT.
  • The primary end point was the incidence of new morphometric vertebral fractures.
  • To identify factors associated with fracture risk in men on ADT we compared placebo subjects who suffered a fracture or during the first year on study suffered 7% or greater bone loss with those placebo subjects who did not.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964492.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Schmidt K, Monahan P, Tong Y, Rawl S, Rand K, Cripe LD: Coping styles and psychological outcomes in men with advanced cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e20521

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coping styles and psychological outcomes in men with advanced cancer.
  • : e20521 Background: The psychological outcomes of men with advanced cancer may vary based upon their appraisal and response to the threat of cancer.
  • Coping styles in other illnesses are influenced by gender and stage of disease, but little is known specifically about men with advanced cancer.
  • METHODS: We recruited 81 men with advanced cancer to complete surveys assessing coping (Mini-MAC), post-traumatic growth (PTGI), and psychological outcomes (Hospital Anxiety and Depression Scale).
  • Fourteen men (17%) scored 8-10 and 8 (10%) scored ≥11 suggesting an anxiety state and disorder, respectively.
  • Eight men (10%) had scores suggesting a depressive state and 4 (5%) a depressive disorder.
  • In addition, greater fatalism was significantly associated with greater post-traumatic growth in all five areas assessed by the PTGI subscales (.27 < r < .36; .001 p < .032).
  • CONCLUSIONS: As expected men with advanced cancer report anxiety and depression.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961013.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Saad F, Smith MR, Egerdie B, Tammela TL, Feldman RA, Heracek J, Szwedowski M, Ke C, Leder B, Goessl C: Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC). J Clin Oncol; 2009 May 20;27(15_suppl):5056

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC).
  • Previously, we reported that denosumab, a fully human monoclonal antibody against RANKL, increased BMD and reduced the incidence of vertebral fractures in men with PC on ADT.
  • METHODS: Men receiving ADT for nonmetastatic PC were randomized to receive subcutaneous denosumab 60 mg every 6 months (n = 734) or placebo (n = 734), with daily calcium and vitamin D supplements for 3 years.
  • Men < 70 years old were required to have low BMD or a history of osteoporotic fracture.
  • RESULTS: As previously reported, denosumab reduced the incidence of new vertebral fractures by 62% (p = 0.006), fractures at any site by 28% (p = 0.10), and multiple fractures at any site by 72% (p = 0.006) over 3 years.
  • CONCLUSIONS: Denosumab significantly reduced the incidence of new vertebral fractures and in a post-hoc analysis, showed a trend toward a positive effect on nonvertebral fractures in men receiving ADT for nonmetastatic PC.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962972.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Snyder CF, Frick KD, Blackford AL, Herbert RJ, Neville BA, Carducci MA, Earle CC: Costs of treatments for local/regional prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):6527

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 6527 Background: Men with prostate cancer have a variety of treatment options, including surgery, radiation, hormonal therapy, combinations thereof, or active surveillance.
  • METHODS: Using the SEER-Medicare database, we examined the Inpatient, Outpatient, Emergency, and Other costs of men diagnosed with local/regional prostate cancer in the year 2000 who were 66+ years old and enrolled in the fee-for-service Medicare program.
  • Based on the treatments received in the first 9 months from diagnosis, men were assigned to these treatment groups: active surveillance, radiation, hormonal, hormonal+radiation, surgery (might also include radiation and hormonal therapy).
  • We estimated the costs of prostate cancer care from 1 month pre- to 12 months post-diagnosis by calculating the incremental costs of care for cases vs.
  • CONCLUSIONS: The treatment choice of men with local/regional prostate cancer has important implications for cost in the year following diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964033.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Winkfield KM, Chen M, Dosoretz DE, Salenius SA, Katin MJ, Ross R, D'Amico AV: Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate. J Clin Oncol; 2009 May 20;27(15_suppl):5068

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
  • METHODS: The study cohort was comprised of 4,880 men with clinical stage T1-3N0M0 prostate cancer and minimum follow-up of 2 years who underwent brachytherapy-based treatment at 20 centers within the 21st Century Oncology consortium.
  • A Cox regression multivariable analysis was used to evaluate the risk of death in African-American (AA) and Hispanic (H) men as compared to Caucasian men adjusting for age, pretreatment PSA, Gleason score, clinical T stage, year and type of treatment, and comorbidity level.
  • CONCLUSIONS: African-American and Hispanic race as compared to white race appear to confer a higher risk of mortality following brachytherapy-based treatment in men with localized or locally advanced prostate cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964249.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Kyrdalen AE, Hernes E, Fossa SD, Dahl AA: Chronic fatigue in prostate cancer patients after radical prostatectomy (RP) or high-dose radiotherapy (RAD). J Clin Oncol; 2009 May 20;27(15_suppl):5164

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Caseness of CF was observed in 13.6% of men with RP (95%CI 9.9-17.2%) and in 25.7% after RAD (95%CI 19.4-32.0%) (p = 0.001).
  • The prevalence in the RP group was similar to the norm observed in Norwegian men >60 years.
  • In multivariate regression analysis treatment modality did not show any significant association with CF (p = 0.25).
  • Bowel bother was more common after RAD, and showed a significant association with CF caseness, however, with a wide confidence interval.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964505.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Lawrence YR, Morag O, Boyko V, Benderly M, Goldbourt U, Barchana M, Behar S, Wolf I, Dicker AP, Catane R: Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):5158

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer.
  • Metabolic syndrome (MS) is a cluster of medical disorders (hypertension, dyslipidaemia, hyperglycaemia, obesity) associated with the subsequent development of diabetes mellitus (DM).
  • METHODS: The Bezafibrate Infarction Prevention study was a randomized trial of fibrate therapy for the secondary prevention of ischemic heart disease.
  • Between 1990-2 15524 men and women with ischemic heart disease were screened, of whom 3090 entered the trial.
  • DM was defined by medical history or fasting glucose > 125 mg/dL.
  • RESULTS: 1350 participants were excluded due to missing data or previous cancer diagnosis, leaving 11,541 men.
  • CONCLUSIONS: A baseline diagnosis of DM (highly significant) or MS (trend) was associated with a decreased prostate cancer rate over the subsequent 12 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964472.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Dale W, Bilir SP, Hemmerich J, Basu A, Meltzer DO: Logical inconsistency in comorbid health state preference assessment for prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):6568

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Men were surveyed at the time of prostate biopsy.
  • CS were combinations of the SS "impotence" with each of incontinence, asymptomatic localized disease, and post-prostatectomy.
  • Regression analysis showed the association of other survey elements to utility inconsistency.
  • CONCLUSIONS: Over two thirds of men gave at least one logically inconsistent response across the three CS conditions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963806.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Olsson H, Attner B, Noreen D, Lithman T: Comorbidity prior to diagnosis in patients with common cancer diagnoses. J Clin Oncol; 2009 May 20;27(15_suppl):e22180

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comorbidity prior to diagnosis in patients with common cancer diagnoses.
  • : e22180 Background: Chronic disease as diabetes, hypertonia and anemia may be associated with cancer risk as well as affect the short term survival of the malignancy.
  • Comorbidity was studied prior to cancer diagnosis and in order to compare with the general population all first comorbidity diagnoses within 90 days were censored.
  • Patients with lung cancer had a higher prevalence of anemia, KOL, diabetes, rheumatoid arthritis for both men and women and for men also a higher prevalence of alcohol related diseases.
  • Survival of the different cancer diagnoses was not significantly related to the comorbidity except for a tendency of worse survival for patients with alcohol related disease.
  • Our study also indicates the necessity to have all levels of care included in the study base of comorbidity and also emphasizes the need to censor time prior to diagnosis when comparing data with the general population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963595.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Granberg C, Thompson RH, Quevedo JF, Karnes RJ, Frank I, Kwon ED, Blute ML: Down-staging of locally advanced prostate cancer with anti-CTLA-4 monoclonal antibody prior to radical prostatectomy. J Clin Oncol; 2009 May 20;27(15_suppl):e16103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16103 Background: At present, androgen ablation (AA) therapy ± radiation therapy represents a first-line treatment for patients with unresectable locally advanced prostate cancer (CAP), typically resulting in palliative disease control.
  • Here, we discuss the outcomes of 5 locally advanced CAP patients treated with the monoclonal antibody MDX-CTLA-4 (MDX-010) + AA who subsequently underwent radical prostatectomy (RP), 2 of whom exhibited striking down-staging of their disease.
  • RESULTS: All men had unresectable, locally advanced disease (stage T2c-T4) prior to treatment with AA + MDX-010 and subsequently underwent RP.
  • Of the 5 patients, 2 exhibited dramatic and indisputable down-staging of their disease.
  • Both had T4 disease pre-treatment, and had stage T2c on final pathology.
  • One patient is free of disease with undetectable PSA for 19 months following adjuvant radiation treatment but no further therapy, while the other patient is awaiting follow-up.
  • This therapeutic modality exhibits significant promise for men with unresectable disease and may provide durable and potentially curative cancer control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963333.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Horvath L, Zhao L, Lee B, Brown D, Molloy M, Marx G, Boyer M, Breit S, Sutherland R, Henshall S: Identification of candidate biomarkers of therapeutic response to docetaxel in hormone-refractory prostate cancer by proteomic profiling. J Clin Oncol; 2009 May 20;27(15_suppl):11010

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 11010 Background: Docetaxel (DTX)-based chemotherapy improves symptoms and survival in men with advanced hormone-refractory prostate cancer (HRPC).
  • Plasma/serum samples were collected from 41 men with metastatic HRPC treated with DTX-based chemotherapy (36 with paired samples pre- and post- cycle 1 DTX).
  • The association between MIC-1 levels, PSA response and overall survival (OS) were assessed by non-parametric tests and Kaplan-Meier survival analysis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963974.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Christiansen CF, Johansen MB, Christensen S, Langeberg W, Fryzek JP, Toft Sørensen H: Incidence of acute kidney injury in cancer patients: A population-based cohort study in Denmark. J Clin Oncol; 2009 May 20;27(15_suppl):9570

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, we examined the incidence of AKI within the first year after cancer diagnosis to estimate the magnitude of this risk and better understand which patients are at greatest risk.
  • METHODS: Using the population-based Danish Cancer Registry, we conducted a retrospective cohort study of 4,427 men and women from North Jutland, Denmark (population 500,000) diagnosed with cancer from 2002 to 2003 (non-melanoma skin cancer excluded).
  • AKI was defined according to the Risk/ Injury/ Failure/ Loss/ End-stage-renal-disease (RIFLE) criteria.
  • Baseline sCr was defined as the lowest sCr in the year before cancer diagnosis.
  • We compared this value to the highest sCr on record during the first year following cancer diagnosis to identify those who experienced an AKI.
  • RESULTS: Median age for the cohort was 68.6 years, 50.9% were men, and the most common cancer sites were lung (14.2%), breast (13.7%), prostate (9.8%), colon (9.6%), rectum (5.1%), and bladder (6.3%).
  • Incidence was highest among patients aged 80 years or older (531 per 1,000 person-years, 95% CI 464-606) and in those with cancer of the liver (1,221, 95%CI 676-2,205), pancreas (1,472, 95%CI 1,130-1,917), or kidney (1,254, 95%CI 974-1,616), or with multiple myeloma (855, 95%CI 538-1,356).
  • Our study showed that over 20% of cancer patients may experience acute kidney injury in the first year after diagnosis.
  • Older patients and those with cancer of the liver, pancreas, or kidney, or with multiple myeloma are especially at risk for AKI.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963659.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Pohl A, Zhang W, Yang D, Lurje G, Ning Y, Khambata-Ford S, Langer C, Kahn M, Teo JL, Lenz HJ: Association of CD133 polymorphisms and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with either first-line 5-FU + bevacizumab (BV) or second-line irinotecan (IR)/cetuximab (CB) or IR alone. J Clin Oncol; 2009 May 20;27(15_suppl):4062

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of CD133 polymorphisms and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with either first-line 5-FU + bevacizumab (BV) or second-line irinotecan (IR)/cetuximab (CB) or IR alone.
  • RESULTS: 79 pts (47 men, 32 women) received FOLFOX/BV or XELOX/BV.
  • The second cohort consisted of 186 pts (103 men, 83 women).
  • Combined analysis of rs2286455 and rs3130 showed a significant association with PFS (p= 0.010, log-rank test) in pts receiving FOLFOX/BV or XELOX/BV.
  • Multivariate analysis showed a significant association with PFS in first-line setting for rs2286455 and rs3130 (adjusted p=0.012) and a trend in second-line setting for rs2240688 (adjusted p=0.086).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961591.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. The quality of older people's relationships may reduce disability. Nurs Stand; 2010 Jun 23;24(42):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Older men who live alone could alleviate the risk of disability onset by becoming socially active.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28019488.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


32. Newnham D: OutsideIn. Nurs Stand; 2009 May 27;23(38):26-27

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : My neighbour Gerald was philosophical about his diagnosis.
  • 'The doctor says more men die with prostate cancer than of it,' he told me.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996769.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


33. Moseley A: Hypothyroidism. Nurs Stand; 2009 Jun 10;23(40):59-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : As a second-year nursing student, understanding hypothyroidism is important because it is one of the most common endocrine conditions, affecting one in 50 women and one in 300 men ( Vanderpump et al 1995 ).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996643.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. Richings J: Limited definition of intuition. Nurs Stand; 2005 Mar 30;19(29):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : With regard to Jean Faugier's feature (February 23), I am surprised that intuition can be spoken about in a such a gendered way: 'Women historically pre-dated men in the caring business… intuition has caused problems for women. '

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27985097.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


35. Shim K, Potvin KR, Mills K, Whiston F, Stitt L, Winquist E: Risk factors for thromboembolic events in testicular cancer patients receiving chemotherapy. J Clin Oncol; 2009 May 20;27(15_suppl):e16109

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical experience and the literature have suggested that men receiving cisplatin-based chemotherapy for metastatic germ cell tumors are at particularly high risk.
  • METHODS: All men treated with cisplatin-based chemotherapy for metastatic germ cell cancer at the London Regional Cancer Program from January 1978 to December 2007 were identified from electronic databases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963332.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Cescon DW, Canil C, Le LW, Tannock IF: Use of the Prostate Cancer-specific Quality of Life Instrument (PROSQOLI) in clinical practice. J Clin Oncol; 2009 May 20;27(15_suppl):e20569

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e20569 Background: Improvement of quality of life (QOL) is a major therapeutic goal for men with advanced prostate cancer (APC).
  • RESULTS: 36 men were recruited, and data collected from 120 clinic visits (85 phase I, 35 phase II).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961125.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Webwise. Nurs Stand; 2010 Mar 31;24(30):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Colorectal cancer is common in the UK, with 37,500 people diagnosed and 16,000 dying with the disease each year.
  • It is the second largest cause of cancer deaths, affecting men and women equally.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029876.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


38. Walsh T: Dementia patients were not starved, inquest finds. Nurs Stand; 2005 Mar 30;19(29):6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : ELEVEN OLDER men whose deaths in a hospital ward in the 1990s sparked accusations that they had been starved by nursing staff died from natural causes, an inquest found last week.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27985078.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


39. Etzersdorfer E, Voracek M, Kapusta N, Sonneck G: Epidemiology of suicide in Austria 1990-2000 : General decrease, but increased suicide risk for old men. Wien Klin Wochenschr; 2005 Jan;117(1-2):31-35

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of suicide in Austria 1990-2000 : General decrease, but increased suicide risk for old men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28124173.001).
  • [ISSN] 1613-7671
  • [Journal-full-title] Wiener klinische Wochenschrift
  • [ISO-abbreviation] Wien. Klin. Wochenschr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; Austria / Epidemiology / Suicide / Suicide prevention
  •  go-up   go-down


40. Risk of lung cancer much higher in men exposed to wood dust. Nurs Stand; 2008 Dec 03;23(13):15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of lung cancer much higher in men exposed to wood dust.
  • However, evidence of its association with other upper aero-digestive tract and respiratory cancers has been inconsistent.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28010359.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


41. Men who eat healthily are more likely to opt for functional foods. Nurs Stand; 2010 Feb 03;24(22):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Men who eat healthily are more likely to opt for functional foods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28029811.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


42. Gravis G, Walz J, Bagattini S, Esterni B, Mimoun C, Salem N, Marcy M, Brunelle S, Viens P, Bladou F: External validation of a nomogram predicting survival in men with metastatic hormone-refractory prostate cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e16066

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] External validation of a nomogram predicting survival in men with metastatic hormone-refractory prostate cancer.
  • The area under the receiver operating characteristics curve was used to estimate the predictive accuracy of the nomogram and calibration plots were used for comparison between predicted and observed probabilities.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963062.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Yung RL, Kurth T, Gaziano JM, Driver JA: Cancer aggressiveness and mortality in men of exceptional age. J Clin Oncol; 2009 May 20;27(15_suppl):11051

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cancer aggressiveness and mortality in men of exceptional age.
  • : 11051 Background: Information on the characteristics of cancer in people ≥ 85 is limited, particularly in men.
  • METHODS: We evaluated the type, grade and extent of cancer among the 22,071 men in the Physicians' Health Study by age at diagnosis (dx) (<65, 65-74, 75-84 and ≥85).
  • All cases of cancer, deaths and cause of death were confirmed by medical record review.
  • For men ≥ 85 the frequency of metastatic cancer at dx increased for prostate (5.8% vs 14.6% p=0.01) and decreased for other GI tumors (63.8% vs 43.5% p=0.05).
  • Cancer as a cause of death decreased among the entire cohort from 44.1% in men aged 55-64 to 20.5% in men ≥ 85, and among those with cancer it decreased from 93.6% to 52.8%.
  • In the matched cohort analysis, the HR for death from all cancers combined declined markedly across categories of increasing age at cancer dx from 10.9 (95%CI:6.0-19.9) in men < 55 to 1.9 (95%CI:1.5-2.4) in men ≥ 85.
  • CONCLUSIONS: In this prospective cohort of apparently healthy U.S. male physicians, characteristics of cancer in men ≥ 85 varied considerably with tumor type and may reflect changes in cancer detection or biology with age.
  • Cancer specific mortality decreased markedly with increasing age of diagnosis for most cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963157.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Robertson Steele W: A genderless cancer. Nurs Stand; 2009 Jul 07;23(44):26-27

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Breast cancer in men accounts for less than 1 per cent of all breast cancers in the UK, but for each man diagnosed it is devastating and life threatening.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28076093.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


45. The Politics of Virginity - Abstinence in Sex Education Alesha E Doan The Politics of Virginity - Abstinence in Sex Education and Jean Calterone Williams Praeger Publishers | 208pp | $44.95 / £31.95 978 0 275 99009 1 0275990095 [Formula: see text]. Nurs Stand; 2009 Aug 05;23(48):31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Given that young men are part of the picture, this is somewhat naive.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28038531.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


46. The long-term impact of stalking on victims. Nurs Stand; 2005 Sep 07;19(52):18

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They report that women are more likely to be the victims, and most stalkers are men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27996412.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


47. Prins R, Rademacher BL, Mongoue-Tchokote S, Eilers KM, Beer TM: C-reactive protein as adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results. J Clin Oncol; 2009 May 20;27(15_suppl):5168

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] C-reactive protein as adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results.
  • : 5168 Background: We previously reported that higher serum concentrations of C-reactive protein (CRP) are associated with shorter survival in men with metastatic CRPC treated with docetaxel-containing chemotherapy.
  • 91% of patients had metastases and 9% had PSA-only disease.
  • This finding also suggests that inflammation may play an important role in the natural history of advanced prostate cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964500.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Okihara K, Takeuchi I, Ukimura O, Takaha N, Kawauchi A, Miki T: Prognostic outcome in Japanese men with prostate cancer treated with androgen-deprivation therapy (ADT) alone: Data from multi-institutional cooperative study in Kyoto Prostate Cancer Registry (KPCR). J Clin Oncol; 2009 May 20;27(15_suppl):e16106

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic outcome in Japanese men with prostate cancer treated with androgen-deprivation therapy (ADT) alone: Data from multi-institutional cooperative study in Kyoto Prostate Cancer Registry (KPCR).
  • : e16106 Background: There is scarce data of ADT alone concerning prognostic outcome in terms of clinical stage, and in comparison with radical treatments specifically in men without metastatic diseases.
  • The aim of this study was to analyze prognostic outcome for ADT alone, and to assess the significant prognostic parameters in Japanese men.
  • RESULTS: Of 1167 men with prostate cancer registered in KPCR, 373 patients (32%) received primary ADT and continued ADT alone during the observation period.
  • Of those men, age and PSA level ranged from 52 to 95 y.o (median: 75) and from 2.17 to 8,650 ng/ml (median: 23.5), respectively.
  • Of the 373 men, 113 men (30%) recurred after the primary ADT.
  • Of the 131men, 36 men (10%) changed from LH-RH monotherapy to CAB, and 46 (12%) and 52 men (14%) underwent anti-androgen alternative therapy and secondary hormonal therapy using estramustine phosphate and/or oral dexamethasone, respectively.
  • CONCLUSIONS: There was substantial number of men with localized disease who were treated ADT alone.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963336.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Correction. Nurs Stand; 2010 Jun 02;24(39):33

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : In the feature 'Men on a mission' (May 19), James Broughton was described as a senior nurse at the NHS blood and transport service.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28030285.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


50. Physical exertion, exercise and cardiac death in women. Nurs Stand; 2006 May 10;20(35):18

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Sudden cardiac death linked to exertion is often unexpected and a concern for clinicians The association between acute exertion and sudden cardiac death is well documented.
  • Among men, it is up to 17 per cent.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27967823.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


51. Success of heart screening service in pharmacies. Nurs Stand; 2010 Apr 06;24(31):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Community pharmacies can provide a cardiovascular risk assessment service in an urban setting that can attract men and provide access for deprived and black and Asian communities.
  • Cardiovascular risk-based screening is proposed as a key intervention to reduce premature cardiovascular disease in the UK and internationally.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28030065.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


52. Ryan J: The learning divide. Nurs Stand; 2009 Jul 15;23(45):77

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Men and women have different learning styles, so how do men cope with the female-dominated environment of pre-registration nurse training?

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28010353.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


53. Hehir B, Lehane M, Drake L, Jebb P: Readers panel - Men at work. Nurs Stand; 2009 Sep 30;24(4):28-29

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Readers panel - Men at work.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28033774.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


54. Schneider A, Schuh A, Maetzel FK, Rückerl R, Breitner S, Peters A: Erratum to: Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women. Int J Biometeorol; 2008 Jul;52(6):549

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Erratum to: Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumFor] Int J Biometeorol. 2008 Jul;52(6):535-47 [18228048.001]
  • (PMID = 28289917.001).
  • [ISSN] 1432-1254
  • [Journal-full-title] International journal of biometeorology
  • [ISO-abbreviation] Int J Biometeorol
  • [Language] eng
  • [Publication-type] Published Erratum
  • [Publication-country] United States
  •  go-up   go-down


55. Erectile dysfunction and inflammation linked to diabetes. Nurs Stand; 2006 Aug 23;20(50):16-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Infection with cytomegalovirus or Chlamydia pneumoniae (pictured above) is associated with erectile dysfunction in men with diabetes.
  • In diabetic men with erectile dysfunction, endothelial dysfunction is a major underlying cause.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27991166.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


56. Foerster R, Foerster FG, Baaske D, Schubotz B, Wulff V, Rudlowski C: Metastatic male breast cancer (mMBC): Prognosis and survival of 35 patients. J Clin Oncol; 2009 May 20;27(15_suppl):e12001

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e12001 Background: Only about 1% of breast cancers occur in men, respectively 400-500 new cases per year in Germany.
  • Clinical studies on breast cancer in men are limited for case studies or retrospective analysis.
  • METHODS: Clinical and pathological tumor characteristics and the follow-up of male breast cancer patients with metastatic disease diagnosed in the region Chemnitz/Zwickau in the state of Saxony between 1995 and 2007 were documented and statistically evaluated.
  • RESULTS: 35 men (median age 64.7 years) were diagnosed with mMBC; 10 (28.6%) of them with primary metastasis.
  • Tumor characteristics at the point of diagnosis: 63.9% (n = 22) T2-T4, 38.7% (n = 12) G3, 48.4% (n = 15) N+, 79.3% (n = 23) ER+, 72.4% (n = 21) PgR+, 12.5% (n = 3) HER-2+, 13.8% (n = 4) triple negatives, and 69.2% (n = 9) AR+.
  • The therapy in the metastatic state was very heterogeneous and consisted of systemic endocrine therapy in 45.5% (n = 10), systemic chemo therapy in 9% (n = 2) or a combination of both in 45.5% (n = 10).
  • Our data suggest that an up-to-date adequate systemic therapy is capable of improving survival in men with metastatic breast cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964263.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Treatment for hair loss affects prostate specific antigen. Nurs Stand; 2007 Mar 07;21(26):17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The recommendation for the adjustment of serum prostate-specific antigen (PSA) concentration for screening in men taking 5mg/day finasteride for benign prostatic hyperplasia should also apply to men taking 1mg/day for male pattern hair loss.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27967427.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


58. Sutton EE, Coll MR, Deuster PA: Ingestion of Tyrosine: Effects on Endurance, Muscle Strength, and Anaerobic Performance. Int J Sport Nutr Exerc Metab; 2005 Apr;15(2):173-185

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Acute tyrosine ingestion is thought to improve aerobic endurance, muscle strength and endurance, and anaerobic power of men undergoing severe physiologic stress.
  • In a double-blind, crossover study, 20 men (32 ± 1 y old) underwent 2 loadcarriage treadmill sessions, 1 after taking tyrosine (150 mg/kg L-crystalline tyrosine) and 1 after taking placebo.
  • The results indicate that acute ingestion of tyrosine by healthy men has no measurable effect on endurance, muscle strength, or anaerobic power.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28589768.001).
  • [ISSN] 1543-2742
  • [Journal-full-title] International journal of sport nutrition and exercise metabolism
  • [ISO-abbreviation] Int J Sport Nutr Exerc Metab
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; aerobic endurance / exercise / load carriage / power
  •  go-up   go-down


59. Drewnowska K, Crawford ED, Qian J, Varvel S, Wilk M, Mason L, Kaminetsky J, Huisman TK, Bilowus M, Freedman SJ, Bostwick DG: PCA3: A urine-based genetic assay for detection of prostate cancer in men with elevated PSA. J Clin Oncol; 2009 May 20;27(15_suppl):5054

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PCA3: A urine-based genetic assay for detection of prostate cancer in men with elevated PSA.
  • However, because of low positive predictive values, up to 75% of men with elevated PSA and/or suspicious DRE have a negative biopsy.
  • Urine samples were obtained from 974 men with elevated serum PSA (> 2.5ng/ml) and/or abnormal digital rectal examination prior to routine minimum 10-core prostate biopsy following standard study protocol in 30 medical practices.
  • The mean PCA3 value in men with prostate cancer was significantly higher than in those without cancer (48 vs. 26, p < 0.0001).
  • PCA3 had a specificity of 77% and a sensitivity of 44% for the diagnosis of prostate cancer, while the specificity and sensitivity for serum PSA were 22% and 87%, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962974.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Breunis H, Timilshina N, Tomlinson G, Naglie G, Tannock I, Fleshner N, Krahn M, Duff Canning S, Warde P, Alibhai S: Declines in physical function from androgen deprivation therapy (ADT) in men with nonmetastatic prostate cancer: A matched cohort study. J Clin Oncol; 2009 May 20;27(15_suppl):9526

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Declines in physical function from androgen deprivation therapy (ADT) in men with nonmetastatic prostate cancer: A matched cohort study.
  • METHODS: Men age 50+ with non-metastatic prostate cancer (PC) starting continuous ADT were enrolled in this prospective longitudinal matched cohort study.
  • Self-reported physical function was measured with the Medical Outcomes Study SF-36.
  • CONCLUSIONS: Endurance, upper extremity strength, and self-reported physical function are affected within 3-6 months of starting ADT, particularly in older men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964515.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F, CombAT Study Group: Corrigendum to "The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study" [Eur Urol 2010;57:123-31]. Eur Urol; 2010 Nov;58(5):801

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corrigendum to "The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study" [Eur Urol 2010;57:123-31].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28065365.001).
  • [ISSN] 1873-7560
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Published Erratum
  • [Publication-country] Switzerland
  •  go-up   go-down


62. Sex in cyberspace - men who pay for sex Sarah Earle Sex in cyberspace - men who pay for sex and Keith Sharp Ashgate 135pp £55 978 0 7546 3669 4 9780754636694 [Formula: see text]. Nurs Stand; 2007 May 30;21(38):30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sex in cyberspace - men who pay for sex Sarah Earle Sex in cyberspace - men who pay for sex and Keith Sharp Ashgate 135pp £55 978 0 7546 3669 4 9780754636694 [Formula: see text].
  • : If prostitution is the oldest profession, then the men who visit prostitutes must be the oldest customers.
  • The bulk of the research on prostitution has focused on prostitutes, with little written about the men who use their services.
  • Sarah Earle, lecturer at the Open University, and Keith Sharp, head of the School of Contemporary Studies at the University of Gloucestershire, make these men the focus of their research and raise some fascinating points about sexual identity, sexual services and online forums.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001723.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


63. Guellard K: Women miss out on top jobs as focus falls on men's working rights. Nurs Stand; 2010 Jun 02;24(39):32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Women miss out on top jobs as focus falls on men's working rights.
  • : The encouragement of men in nursing has gone too far (features May 19).
  • Too much focus on 'equality and diversity' is now unfairly favouring men as a nouveau minority group in the profession.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28030284.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Giri VN, Hughes L, Ruth K: Met160Val TMPRSS2 gene polymorphism and early onset prostate cancer in high-risk men. J Clin Oncol; 2009 May 20;27(15_suppl):5000

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Met160Val TMPRSS2 gene polymorphism and early onset prostate cancer in high-risk men.
  • The T-allele of the Met160Val single nucleotide polymorphism (SNP) has been found to be associated with translocation and multiple copies of the TMPRSS2-ERG fusion.
  • This SNP needs clinical characterization in men at high risk for prostate cancer (PCA) (men with a family history [FH] of PCA and African American [AA] men) to determine the role in personalizing PCA early detection.
  • The Prostate Cancer Risk Assessment Program (PRAP) is a prospective screening program for high risk men.
  • Here we evaluated the Met160Val SNP (rs12329760) in the TMPRSS2 gene with respect to race, FH of PCA, and time to PCA diagnosis.
  • METHODS: Eligibility for PRAP includes men ages 35-69 years with one first degree relative with PCA, two second degree relatives with PCA on the same side of the family, any AA man regardless of FH of PCA, and men with BRCA1/2 mutations.
  • Cox models were used for time to PCA diagnosis by risk genotype.
  • RESULTS: Out of 700 men in PRAP, 631 were able to be genotyped for the Met160Val SNP.
  • There was no difference in distribution of genotypes (CT/TT vs. CC) among 231 White men with familial PCA and 400 AA men in PRAP.
  • Among 183 White men with familial PCA with > one follow-up visit, those with the CT/TT genotypes were found to have a significantly earlier time to PCA diagnosis vs. the CC genotype (p = 0.0058).
  • In addition, the hazard ratio for PCA among high-risk White men of the CT/TT genotypes vs CC genotype was 2.55 (p = 0.022) after controlling for age and PSA.
  • No trends were seen among AA men for time to PCA diagnosis for any of the Met160Val SNP genotypes.
  • CONCLUSIONS: The T-allele of the Met160Val variant in the TMPRSS2 gene may be informative of time to PCA diagnosis among White men who have a FH of PCA.
  • This genetic variant warrants further study in high-risk men with familial PCA for its role in personalizing PCA early detection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962898.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Hayes JH, Chen M, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV: Short-course androgen suppression therapy prior to brachytherapy for favorable-risk prostate cancer and the risk of all-cause mortality in men with or without preexisting cardiovascular disease. J Clin Oncol; 2009 May 20;27(15_suppl):5066

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Short-course androgen suppression therapy prior to brachytherapy for favorable-risk prostate cancer and the risk of all-cause mortality in men with or without preexisting cardiovascular disease.
  • : 5066 Background: AST is used to reduce prostate size in men with favorable-risk prostate cancer who have pubic arch interference in order to enable them to undergo prostate brachytherapy.
  • While no disease-specific benefit has been demonstrated to AST in this setting, AST use has been associated with both cardiovascular morbidity and mortality.
  • The Objective is to determine the effect of short-course androgen suppression therapy (AST) prior to brachytherapy on all cause mortality (ACM), stratified by the presence or absence of preexisting cardiovascular disease (CVD).
  • METHODS: The study cohort included 12,792 men with previously-untreated low or intermediate risk prostate cancer (PSA < 20 ng/mL; Gleason score 7 or below on initial biopsy; clinical category T2c or below) treated between 1992 and 2005 at one of 21 community-based medical centers in Illinois, Florida, New York, or North Carolina.
  • Men were treated with brachytherapy with or without neoadjuvant AST.
  • The use of neoadjuvant AST was significantly associated with an increased risk of ACM in men with pretreatment CVD (adjusted hazard ratio (AHR) 1.62, 95% CI, 1.40 to 1.87, p < 0.001) but not in men without CVD (AHR 1.06, 95% CI, 0.91 to 1.25, p = 0.5).
  • In men with preexisting CVD, AST use was associated with an increased risk of ACM at 5 years compared to men with CVD who did not use AST (17.5% (95%CI, 15.57% to 19.64%) vs. 14.35% (95%CI, 12.80% to 16.06%), p < 0.0001).
  • CONCLUSIONS: Preexisting CVD is associated with an increased risk of death in men with favorable-risk prostate cancer treated with short-course AST prior to brachytherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964251.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Igdem S, Abacioglu MU, Alço G, Ibrahimov R, Kefeli A, Çetin I, Turkan S, Okkan S: Postoperative radiotherapy for prostate cancer: Sooner or later? J Clin Oncol; 2009 May 20;27(15_suppl):e16157

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The charts of 139 men who received postoperative radiotherapy (RT) after radical prostatectomy (RP) between 1997-2007 in two institutions were retrospectively analyzed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963417.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Wosnitzer M, Lee DJ, Hirsch AJ, McKiernan JM: Predictors of renal function in nephron sparing surgery for renal cell carcinoma in solitary kidneys. J Clin Oncol; 2009 May 20;27(15_suppl):e16045

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Glomerular filtration rate (GFR) was estimated with the Modification of Diet in Renal Disease (MDRD) equation.
  • Severe chronic kidney disease (CKD) and renal failure were defined as GFR of 15-30 cc/min/1.73m2 and GFR<15, respectively.
  • RESULTS: The study group included 30 men and 8 women with unilateral RCC.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963019.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Villaflor VM, Kanteti R, Watson SM, Karrison T, Vokes EE, Salgia R: Response and survival in African American (AA) patients (pts) with non-small cell lung cancer (NSCLC) treated with erlotinib (E). J Clin Oncol; 2009 May 20;27(15_suppl):e19006

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Data from 44 AA pts (27 women, 17 men) on erlotinib were reviewed.
  • Overall response rate of 13.6% (6-PR, 16-SD, 18-progessive disease, and 4 patients lost to follow up).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962520.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Recchia F, Sica G, Candeloro G, Bisegna R, Necozione S, Bonfili P, Tombolini V, Rea S: Multicenter phase II study of sequential chemotherapy, radiotherapy, and immunotherapy in locally advanced pancreatic (Pa) and biliary tree (Bt) adenocarcinoma (ADK). J Clin Oncol; 2009 May 20;27(15_suppl):3047

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MI with low-dose interleukin-2 (IL-2) and 13-cis-retinoic acid (RA) was given in order to enhance the immune function, which could eradicate minimal residual disease, as previously shown (Clin Cancer Res 2001).
  • METHODS: From September 2003 to September 2007, 54 patients, 32 men, 22 women, 63% with Pa and 37% with Bt ADK, mean age of 63 years (range 36-75), were treated with an ICT consisting of 3 courses of cisplatin, 70 mg/m<sup>2</sup> day 1, gemcitabine 1000 mg/m<sup>2</sup> day 1 and 8 every 3 weeks.
  • Six weeks after completion of CXRT, patients were restaged: In the absence of disease progression, they received, as an MI, IL-2, 1.8 x 10<sup>6</sup> I.U. and RA, 5 mg/kg, 5 days/week, 3 weeks/month for 1 year and thereafter until progression.
  • 15-40%), was observed, with 44.5% of patients achieving stable disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961974.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Rosenfeld MR, Chamberlain M, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X, New Approaches to Brain Tumor Therapy: A CNS Consortium: A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501). J Clin Oncol; 2009 May 20;27(15_suppl):2002

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: There were 97 patients enrolled (60 men); median age 56 yrs (range 21-85); median KPS 90 (range 60-100).
  • Fourteen patients did not start adjuvant treatment (5 patient request and 4 investigator withdrawal; 2 progressive disease; 1 death; 1 toxicity; 1 other).
  • To date 71 of 97 patients have survived at least 12 months from diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964563.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


71. Viudez A, Zárate R, Garrido M, Rodríguez J, Chopitea A, Fernández-Troconiz I, Pardo F, García-Foncillas J: Dose escalation of capecitabine in combination with biweekly cetuximab and hepatic arterial infusion (HAI) of oxaliplatin in patients with liver metastases of colorectal cancer: Preliminary clinical results. J Clin Oncol; 2009 May 20;27(15_suppl):e15080

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: 19 patients (median age: 60; range: 34-74; 52.9% men, 47.1% females) and ECOG performance status of 1 (range 0-2) were treated at 4 DLs (dose level) as follows: DL: 3 pts, DL2: 6 pts, DL 3: 7 pts and DL 4: 3 pts.
  • Disease progression occurred in 15 pts (78.9%; 3 pts in liver only; 4 pts with extrahepatic metastases; 8 cases with both, hepatic and extrahepatic disease).
  • Grade ¾ toxicities including Hand-foot Syndrome in 3 pts (1 pt at DL1, other at DL3 and other at DL4), diarrhoea in 3 pts ( one at DL3 and 2 at DL4), anaemia in 2 pts (DL2 and DL4), asthenia in 2 pts (DL2 and DL4) and mucositis in 1 pts (DL3).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964549.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Chaibi P, Magne N, Breton S, Chebib A, Duron J, Tagzirt M, Hannoun L, Piette F, Khayat D, Spano J: Influence of geriatric consultation with Comprehensive Geriatric Assessment (CGA) on therapeutic decision in elderly cancer patients. J Clin Oncol; 2009 May 20;27(15_suppl):9505

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: 161 patients (57 men, 104 women) (median age 82,4 years, extremes 73 -97) were seen at the geriatric consultation.
  • Geriatric assessment found: severe comorbidity (grade 3 or 4 in CIRS-G scale) in 75 patients, dependance for at least one activity of daily living (ADL) in 52 patients, cognitive impairment in 42 patients, including 13 patients with already diagnosed Alzheimer disease, malnutrition in 104 patients (65 %), depression in 39 patients.
  • Patients for whom final decision was more intensive therapy had significantly more frequent metastatic disease (33/45, p < 0.01) Conclusions: Geriatric evaluation did influence therapeutic decision in 82 % of the patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964456.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Fora A, Fakih M, Scheib S, Hanna T, Raczyk C, Hutson A, Gottlieb R: New CT treatment response score for predicting survival in patients with metastatic colorectal carcinoma: A pilot study. J Clin Oncol; 2009 May 20;27(15_suppl):e15026

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 38 pts (22 men, 16 women, mean age = 62, range = 28-91 ) were included.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964398.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Gorin MA, Iniesta MD, Douglas JA, Milliron KJ, Merajver SD: Absence of the CHEK2*1100delC mutation in non-BRCA1/2 families with multiple cancer types in a high-risk clinic population of Caucasian ancestry. J Clin Oncol; 2009 May 20;27(15_suppl):11040

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Absence of the CHEK2*1100delC mutation in non-BRCA1/2 families with multiple cancer types in a high-risk clinic population of Caucasian ancestry.
  • The contribution of CHEK2 mutations to familial cancer has been widely studied in breast cancer.
  • This finding comes from studies performed on Northern and Eastern European populations.
  • Families were characterized by the presence of several cases of breast and/or ovarian cancer and multiple members with other cancers in a single lineage.
  • RESULTS: No CHEK2*1100delC mutations were detected in 115 individuals, including 39 women diagnosed with breast cancer at an early age, 7 women with bilateral cancer, 2 men with breast cancer and 6 women with ovarian cancer, all of whom were negative for mutations in BRCA1/2.The CHEK2 Breast Cancer Consortium previously reported a frequency of 2.3% for the CHEK2*1100delC mutation among breast cancer cases from families with at least 2 cases of breast cancer (or breast and ovarian cancer) in a first- or second-degree relationship.
  • CONCLUSIONS: Our data are consistent with previous reports that suggest a lower frequency of CHEK2*1100delC mutations in North American hereditary breast cancer families without BRCA1/2 mutations and enriched for multiple cancer types.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963982.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Srinivas S, Harshman L, Hauke RJ: Sorafenib monotherapy in patients with treatment-naïve metastatic renal cell cancer: preliminary results of a phase II intra-patient dose-escalation study. J Clin Oncol; 2009 May 20;27(15_suppl):e14564

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e14564 Background: In a phase I dose finding study, the maximum tolerated dose of sorafenib was determined to be 400 mg bid.
  • METHODS: Patients with treatment-naïve metastatic renal cell with clear cell histology were enrolled at Stanford University and the University of Nebraska Medical Center.
  • Patients without DLTs at the end of the second cycle were dose escalated to the highest dose, sorafenib 800 mg bid.
  • The majority (84%) were men.
  • Hand-foot syndrome (skin toxicity) limited escalation in the other 30% of patients.
  • One patient achieved a partial response and seven experienced disease stabilization.
  • The main toxicity limiting escalation was hand-foot syndrome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963689.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Dômont J, Salas S, Lacroix L, Brouste V, Dufresne A, Terrier P, Blay J, Le Cesne A, Coindre J, Benard J, Bonvalot S: Frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis as a surrogate marker for disease management. J Clin Oncol; 2009 May 20;27(15_suppl):10501

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis as a surrogate marker for disease management.
  • : 10501 Background: Fibromatosis, a rare soft-tissue and locally invasive neoplasm, consist of distinct clinical entities including sporadic extra-abdominal fibromatosis (EAF).
  • From this cohort, 101 pts with EAF surgically treated with curative intent and follow-up allowed us to relate βC mutational status to disease outcome.
  • There were 36 men and 65 women.
  • Few pts were treated after surgery with radiation therapy (18%) and medical treatment (8%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963688.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Chang M, Won Y, Han J, Kim H, Kwon O, Lee J, Park Y, Ahn J, Ahn M, Park K: Prognostic role of insulin-like growth factor receptor-1 (IGFR-1) and insulin-like growth factor binding protein-3 (IGFBP-3) expression in small cell lung cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e22155

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Median age was 63 years (range 38-85), 84% were men.
  • One hundred-seventeen patients had extensive disease (60.3%), and 77 had limited disease (39.7%).
  • However, 84% of 115 extensive disease patients showed IGFR-1 positivity.
  • The subgroup analysis revealed that OS was significantly longer for patients with IGFR-1 positive compared to those with IGFR-1 negative in extensive disease (11.3% vs 0% at 2year, p=0.034).
  • CONCLUSIONS: These results suggest that IGFR-1 expression may be useful as a prognostic marker in patients with extensive disease of SCLC.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963547.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Badalato G, Barlow L, Benson M, McKiernan J: Is age at the time of surgery a predictor of biochemical failure following radical prostatectomy? J Clin Oncol; 2009 May 20;27(15_suppl):e22110

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Using the Columbia Urologic Oncology Database, a retrospective analysis of 3,736 men treated with open or robotic-assisted laparoscopic radical prostatectomy for prostate cancer from 1988 to 2008 was conducted.
  • CONCLUSIONS: Older patients who undergo radical prostatectomy for prostate cancer appear to have an increased risk of recurrence, which is most notable in patients with low-grade disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963507.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Begum M, Robinson L, Sommers E, Bepler G: The impact of PET-based staging on survival of patients with stage I lung cancer. J Clin Oncol; 2009 May 20;27(15_suppl):7570

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Stage I, as defined by Mountain in 1997, includes tumors of any size located within one lobe of the lung without involvement of the parietal pleura, a distance of 2 cm or more from the carina, and no evidence for metastatic disease in any pulmonary, hilar, or mediastinal lymph node or distant site.
  • Description of pts: 638 women, 592 men; 11 African-American, 1215 Caucasian; 18 Hispanic, 1202 Non-Hispanic; age range 28.1-94.0 y, mean 68.9 y, median 69.9 y; 26 pneumonectomies, 243 segmentectomies or wedge resections; 699 adeno-, 15 adenosquamous, 325 squamous, 25 large cell, 57 neuroendocrine carcinomas; maximum tumor diameter range 0.1-25 cm, mean 2.9 cm, median 2.3 cm; 477 dead (survival 0.0-138.8 months), 753 alive (survival 0.1-144.4 months).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963355.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Sekine I, Sumi M, Ito Y, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T: Phase I study of concurrent high-dose three-dimensional conformal radiotherapy (3D-CRT) without elective nodal irradiation with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small cell lung cancer (NSCLC). J Clin Oncol; 2009 May 20;27(15_suppl):7546

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 26 men and 5 women with a median (range) age of 60 (41-75) years.
  • Of these, 23 (74%) had adenocarcinoma and 20 (65%) had stage IIIA disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963322.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Gillison TL, Appleman LJ, Friedland DM, Evans TL, Lara PN, Gooding WE, Lenzner DE, Strausser HM, Gingrich JR, Chatta GS: Docetaxel and imatinib every 21 days for castration resistant prostate cancer: A phase II trial. J Clin Oncol; 2009 May 20;27(15_suppl):e16086

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e16086 Background: Docetaxel (D) IV every 21 days, is the only cytotoxic agent that prolongs survival in men with castrate resistant prostate cancer (CRPC).
  • No objective responses were seen by CT imaging among 10 pts with measurable disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963108.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Oh WK, Febbo PG, Richie JP, Fennessy FM, Scibelli G, Hayes JH, Choueiri TK, Tempany CM, Taplin ME, Ross RW: A phase II study of neoadjuvant chemotherapy with docetaxel and bevacizumab in patients (pts) with high-risk localized prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. J Clin Oncol; 2009 May 20;27(15_suppl):5060

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Eligibility included any of the following: PSA > 20 ng/ml or PSA velocity > 2 ng/ml/yr, cT3 disease, any biopsy Gleason 8-10, Gleason 7 with T3 disease by endorectal (er) MRI.
  • Also, >50% biopsy cores involved and either Gleason 7 or PSA >10 or cT2 disease were eligible.
  • CONCLUSIONS: Neoadjuvant docetaxel and bevacizumab demonstrates clinical evidence of activity in men with high-risk localized prostate cancer, with a 39% PR rate by erMRI and PSA declines noted in 65%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962979.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Lim J, Kim J, Yi H, Kim H, Lee M, Kim C: S-1 monotherapy for the treatment of elderly patients with advanced gastric cancer. J Clin Oncol; 2009 May 20;27(15_suppl):e15671

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The patients consisted of 11 men and 6 women whose median age was 77 years (range: 71-83) with their performance status in 1 to 2.
  • Five patients had recurrent AGC and the other 12 patients metastatic AGC at the time of diagnosis.
  • Response rate was 17.6% (95% Condifence Interval, 0 to 35.7); Complete remission in 0, partial remission in 3 (17.6%) and stable disease in 5 patients (29.4%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962843.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Kersten S, Wein A, Albrecht H, Reulbach U, Maennlein G, Wolff K, Ostermeier N, Hohenberger W, Hahn EG, Boxberger F: Palliative systemic chemotherapy with gemcitabine (GEM) and 5-fluorouracil (5-FU) as 24h-infusion in patients with advanced inoperable biliary tract cancer (UICC stage IV). J Clin Oncol; 2009 May 20;27(15_suppl):e15633

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e15633 Background: Due to the late diagnosis of biliary tract carcinomas in an advanced tumor stage, the application of palliative chemotherapy frequently remains as a possible treatment option.
  • RESULTS: Median age: 64 years; men/women: n=18/17; ECOG 0/1/2: n=10/21/4; localisation: intrahepatic bile ducts: n=19, extrahepatic bile ducts: n=11; gall bladder: n=4; metastases: liver: 91.4%, lymph nodes: 51.4%, peritoneum: 28.8%, bones: 8.6%, intestine: 8.6%, skin: 2.9%, lungs: 2.9%; chemotherapy applications: total number: 486, average value/patient: 13.9; CA 19-9 elevated yes/no: n=13/22 (37.1%/62.9%); CEA elevated yes/no: n=15/9 (42.9%/25.7%, not evaluable: 11); higher grade toxicity (III or IV): leukocytopenia III: 14.3%, thrombocytopenia III: 2.9%, weariness III: 2.9%, diarrhea III: 5.7%, diarrhea IV: 2.9%, vomiting IV: 2.9%, pain III: 5.7%, ascites III: 5.7%, infections III: 2.9%, thromboembolia IV: 2.9%, elevated bilirubin value III: 1.7%, grade IV: 8.3%; deep leg vein thrombosis: 15%; median TTP: 5.1 months (95% CI: 2.9 - 7.2); median overall survival: 10.4 months (95% CI: 7.9 - 12.9); 6-months-/1-year-/2-year-survival rate: 65.7%/45.7%/17.1%; response rate: PR: n=5 (14.3%), SD: n=18 (51.4%), PD: n=7 (20%), not evaluable: n=5 (14.3%); tumor control (PR/SD): n=23 (65.7%); median follow-up: 10.4 months.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962748.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Schultz NA, Roslind A, Christensen IJ, Gaustadnes M, Johansen JS, Kruhøffer M, Horn T, Wøjdemann M: KRAS mutations and relation to prognosis in patients operated for localized pancreatic cancer and other periampullary cancers. J Clin Oncol; 2009 May 20;27(15_suppl):e15618

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For the present pilot study cancer tissue blocks were collected from 58 patients (31 men, 27 women, median age 64, range 33-81 years, ASA 1-3).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962729.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


86. Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, Worden FP: Phase II trial evaluating imatinib (I) in patients (pts) with anaplastic thyroid carcinoma (ATC). J Clin Oncol; 2009 May 20;27(15_suppl):6057

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Pts ≥ 18 years old with histologically confirmed ATC, overexpressing PDGFR or c-Abl by immunohistochemistry who had measurable disease were eligible.
  • Pts with complete response (CR)/partial responses (PR)/stable disease (SD) were treated until disease progression.
  • RESULTS: From February 2004 to May 2007, eleven pts from our institution were enrolled and were started on (I) (6 men; 5 women) with a median age of 63 years (ranges 53-80).
  • At baseline, 4/11 pts (36%) had locoregional disease, 5/11 pts (45%) had distant metastases, and 2/11 pts (18%) had both.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961934.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Dennis PA, Blumenthal G, Ballas M, Gardner E, Kawabata S, LoPiccolo J, Helsabeck C, Root H, Figg WD, Bernstein W: A phase I study of nelfinavir, an FDA approved HIV protease inhibitor, in adults with refractory solid tumors. J Clin Oncol; 2009 May 20;27(15_suppl):2583

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therapy continued until MTD or disease progression.
  • Of the 11 evaluable for toxicity, there were 10 men, 10 Caucasians, and 1 African American (median age 63 years (range 24 - 77)).
  • Two subjects with lung cancer had stable disease for 9 weeks.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961900.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Hoffman KR: Understanding among medical oncologists of the true monetary cost of therapy. J Clin Oncol; 2009 May 20;27(15_suppl):6629

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Understanding among medical oncologists of the true monetary cost of therapy.
  • : 6629 Background: While oncologists are educated to deal with the medical complexities of their treatment, a new side effect, that of financial toxicity, has arisen over the past several years.
  • METHODS: 50 medical oncologists agreed to take a survey judging their knowledge of the financial cost of the treatments used in patients with the five most common tumors treated in the office: breast cancer, non-small cell lung cancer, colorectal cancer, non-Hodgkin's lymphoma, and three other commonly treated cancers: chronic myelogenous leukemia, multiple myeloma and ovarian cancer.
  • A body surface area of 1.8 M2 for men and 1.6 M2 for women was used.
  • RESULTS: 39 medical oncologists completed the entire survey.
  • CONCLUSIONS: Medical oncologists have a poor understanding of the monetary costs of the newer treatments they are prescribing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961808.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Yoshida Y, Hasegawa J, Nezu R, Kim Y, Hirota M, Yoshikawa K, Kawano K, Izumi H, Kohno K: Clinical usefulness of mtTFA expression as a predictive marker in colorectal cancer patients treated with FOLFOX. J Clin Oncol; 2009 May 20;27(15_suppl):4059

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They consisted of 25 women (42.4%) and 34 men (57.6%), with a median age of 62 years (29-84).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961583.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Luong NV, Kantarjian HM, Faderl SH, Thomas DA, Vu KD: Occurence of venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL), or lymphoblastic leukemia (LL). J Clin Oncol; 2009 May 20;27(15_suppl):7059

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Medical records of 299 ALL pts were reviewed and analyzed.
  • Women were 1.8 times (95%CI: 1.04-3.4) more likely than men to have a VTE.
  • In a multivariate model, significant predictors of VTE were age 40-59 yrs, plt count 50-99 x 10<sup>9</sup>/L, diagnosis of Ph-positive ALL, history of VTE, and OCP/HRT use.
  • In addition to traditional risk factors, disease-specific features may also predispose pts to higher VTE risk.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961450.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Ghobrial IM, Matous J, Padmanabhan S, Badros A, Chuma S, Leduc R, Rourke M, Kunsman J, Harris B, Warren D, Richardson P: Phase II trial of combination of bortezomib and rituximab in relapsed and/or refractory Waldenstrom macroglobulinemia. J Clin Oncol; 2009 May 20;27(15_suppl):8535

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Patients who had at least one previous therapy for WM and who had relapsed or refractory disease were eligible.
  • RESULTS: 37 pts (26 men and 11 women, median age 62 years, range 42 - 73) have been treated to date.
  • Progressive disease occurred in 1 (3%) and stable disease occurred in 5 (14%).
  • At 24 months of follow up, 8/35 pts have shown relapsed disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27960930.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Ali RA, Asadollah M, Hossien RA: The Role of Unknown Risk Factors in Myocardial Infarction. Cardiol Res; 2010 Dec;1(1):15-19
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The majority of our patients were old men in the age range of 60 - 69 years.
  • So we recommend that governments and heart associations must introduce new plans and policies in order to tackle the problem and reduce the frequency of cardiovascular disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 2001 Jan 30;103(4):491-5 [11157711.001]
  • [Cites] JAMA. 2003 Aug 20;290(7):898-904 [12928466.001]
  • [Cites] Circulation. 2003 Jan 28;107(3):363-9 [12551853.001]
  • [Cites] Ann Intern Med. 1999 Jun 1;130(11):933-7 [10375342.001]
  • [Cites] JAMA. 2002 Aug 28;288(8):980-7 [12190368.001]
  • [Cites] JAMA. 2003 Sep 17;290(11):1459-66 [13129985.001]
  • [Cites] JAMA. 2001 May 16;285(19):2481-5 [11368701.001]
  • [Cites] Circulation. 2003 Jan 28;107(3):499-511 [12551878.001]
  • [Cites] Lancet. 1998 Jan 10;351(9096):88-92 [9439492.001]
  • [Cites] Circulation. 2002 Mar 5;105(9):1135-43 [11877368.001]
  • [Cites] JAMA. 2003 Aug 20;290(7):932-40 [12928471.001]
  • [Cites] JAMA. 2001 Nov 7;286(17):2136-42 [11694155.001]
  • [Cites] Circulation. 2000 Oct 31;102(18):2165-8 [11056086.001]
  • [Cites] JAMA. 2003 Aug 20;290(7):891-7 [12928465.001]
  • [Cites] Circulation. 2003 Sep 23;108(12):1428-31 [12975260.001]
  • [Cites] Circulation. 2000 Apr 18;101(15):1767-72 [10769275.001]
  • [Cites] Circulation. 2004 Feb 10;109(5):647-55 [14744975.001]
  • [Cites] N Engl J Med. 2002 Jul 4;347(1):5-12 [12097534.001]
  • (PMID = 28352371.001).
  • [ISSN] 1923-2829
  • [Journal-full-title] Cardiology research
  • [ISO-abbreviation] Cardiol Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; Arteriosclerosis / Inflammation / Myocardial infarction / Risk factors
  •  go-up   go-down


93. Lassman AB, Oligodendroglioma Study Group: Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors. J Clin Oncol; 2009 May 20;27(15_suppl):2014

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We retrospectively identified adults with newly diagnosed anaplastic oligodendroglioma (AO) or oligo-astrocytoma (AOA) seen at 17 medical centers from 1981-2007 exclusive of phase III or bone marrow transplant trials.
  • RESULTS: There were 1054 patients: 594 men, 460 women; median age 42 (18-88); 661 with AO, 443 with AOA.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964586.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Vieitez J, Jiménez Fonseca P, Fernandez de Sanmamed M, Pitiot AS, Crespo G, Berros J, Muriel C, Izquierdo M, Pardo P, Lacave A: Incidence and significance of K-RAS mutation in first line treatment of colorectal cancer (cc): Experience of a single institution (Hospital Universitario Central de Asturias (HUCA)). J Clin Oncol; 2009 May 20;27(15_suppl):e15081

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence and significance of K-RAS mutation in first line treatment of colorectal cancer (cc): Experience of a single institution (Hospital Universitario Central de Asturias (HUCA)).
  • 62 were men and 32 female.
  • Multivariable Cox analysis did not find any significant difference between sex (p=0.78), primary resected organ (p=0.28), liver metastases (p=0.37), LDH value at diagnosis (p=0.0.43), employ of biological agents in first line (p=0.37) or mutation in K-RAS gene (p=0.68).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964548.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Lin J, Beer TM, Ryan CJ, Mathew P, Wilding G, Morris M, Callahan JA, Gordon G, Reich S, Carducci MA: A randomized, phase II study of ATN-224 in patients with biochemically relapsed, hormone-naive prostate cancer: A DOD/PCF Prostate Cancer Clinical Trials Consortium trial. J Clin Oncol; 2009 May 20;27(15_suppl):5135

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: ATN-224 may have biologic activity in men with androgen-dependent PCa at low doses, as demonstrated by > 50% of pts being PSA progression free at 6 month and a significant decrease in mean PSA slope.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964427.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Baik CS, Strauss GM, Feskanich D: A prospective study of reproductive factors, hormone use, and risk of lung cancer in postmenopausal women. J Clin Oncol; 2009 May 20;27(15_suppl):1501

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 1501 Background: There has been increased interest in understanding the role of hormonal factors in lung cancer (LC) in women with the observation that it exhibits different epidemiologic patterns and treatment response when compared to men.
  • No association was seen in former smokers.
  • No significant association was seen when assessed by duration of PMH use, time since last use, or type of PMH.
  • CONCLUSIONS: These results suggest that there may be an association between hormonal factors and LC development, and further suggest that the mechanism may differ in smokers versus lifelong never smokers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964314.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Bloch J, Mouawad R, Spano J, Vigniot S, Magné N, Khayat D: Long-term follow-up of endogenous erythropoietin, VEGF levels and red blood count in patients receiving different antiangiogenic treatment. J Clin Oncol; 2009 May 20;27(15_suppl):e14648

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: 30 patients (20 men and 10 women) with different cancer type (20 RCC and 10 thyroids) with a median age of 56 year were included in this study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27964238.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Kohli S, Szydlo DW, Novotny PJ, Yang P, Brown PD, Buckner JC, Sloan JA: Longitudinal assessment of cognitive impairment among lung cancer survivors. J Clin Oncol; 2009 May 20;27(15_suppl):9609

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Between 2005-2008, we followed 1757 primary LC patients who responded to CF questions at least once within 8 years of diagnosis.
  • Overall QoL measured by LCSS and LASA (scores 0-100 from worst to best) were assessed among 1,604 of 1,757 (91%) who completed the questionnaire at one or both of two time periods: short-term (T1-within 3 years of diagnosis) and long-term follow-up (T2-beyond 5 years of diagnosis).
  • RESULTS: The median age at the time of LC diagnosis was 68 years in men (n=834) and 65 years in women (n=770), p<0.0001.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963845.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Owusu C, Koroukian S, Madigan E: Correlates of hospice use in elders with cancer. J Clin Oncol; 2009 May 20;27(15_suppl):9579

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We aim to identify correlates of hospice in elders with cancer, hypothesizing that the presence of functional limitations and geriatric syndromes are associated with hospice use, independently of age and comorbidities.
  • METHODS: The study population included Ohio residents age 65 years or older, diagnosed with breast (n=774), prostate (n=271), or colorectal cancer (n=1,011) during the period 07/1999-12/2001, receiving care through the Medicare fee-for-service system, and first receiving home health care (HHC) in the 30 days before or after cancer diagnosis.
  • In addition to descriptive analyses, multivariable logistic regression analysis was conducted to evaluate the association between hospice use, comorbidity, functional limitations, and geriatric syndromes, after adjusting for patient and tumor attributes.
  • Hospice use increased significantly with age, and was higher among men than women.
  • Conversely, hospice use was significantly higher (p < 0.001) among patients with functional limitations (24.0% vs. 16.5% in all others), and those with geriatric syndromes (23.8% vs. 15.3% in all others).
  • Results from the multivariable logistic regression analysis indicated that comorbidities and functional limitations were not associated with hospice use, whereas patients with geriatric syndromes were 1.5 times as likely as those without geriatric syndromes to use hospice (adjusted odds ratio (AOR): 1.5, 95% confidence interval (1.2-1.9).
  • Given marked differences in the disease trajectory across the anatomical cancer sites, future studies should analyze these associations separately in breast, prostate, and colorectal cancer patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963720.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. De Vita F, Orditura M, Innocente R, Vecchione L, Pinto C, Chiarion Sileni V, Martinelli E, Ruol A, Catalano G, Ciardiello F: A multicenter phase II study of induction CT with FOLFOX-4 and cetuximab followed by RT and cetuximab in locally advanced esophageal cancer (LAEC). J Clin Oncol; 2009 May 20;27(15_suppl):4546

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Up to December 2008, 40 pts, 30 men, were enrolled from 4 institutions; median age 59 y (35-70y); AC 12; SCC 28; stage II 15, stage III 25 pts.
  • The most frequent grade 3/4 toxicity of chemoradiotherapy were skin (32%),neutropenia (29%) and esophagitis (9%); 10 pts had no resection (9 progressive disease,1 patient's refusal).
  • The pathological response rate was 68 %, with a complete histopathological remission recorded in 6 pts (27%);17 pts (53%) are still alive without residual or recurrent disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963011.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement